19854267|t|In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.
19854267|a|Numerous studies have demonstrated oxidative damage in the central nervous system in subjects with Alzheimer disease and in animal models of this dementing disorder. In this study, we show that transgenic mice modeling Alzheimer disease-PDAPP mice with Swedish and Indiana mutations in the human amyloid precursor protein (APP)-develop oxidative damage in brain, including elevated levels of protein oxidation (indexed by protein carbonyls and 3-nitrotyrosine) and lipid peroxidation (indexed by protein-bound 4-hydroxy-2-nonenal). This oxidative damage requires the presence of a single methionine residue at position 35 of the amyloid beta-peptide (Abeta), because all indices of oxidative damage in brain were completely prevented in genetically and age-matched PDAPP mice with an M631L mutation in APP. No significant differences in the levels of APP, Abeta(1-42), and Abeta(1-40) or in the ratio Abeta(1-42)/Abeta(1-40) were found, suggesting that the loss of oxidative stress in vivo in the brain of PDAPP(M631L) mice results solely from the mutation of the Met35 residue to Leu in the Abeta peptide. However, a marked reduction in Abeta-immunoreactive plaques was observed in the M631L mice, which instead displayed small punctate areas of nonplaque immunoreactivity and a microglial response. In contrast to the requirement for Met at residue 35 of the Abeta sequence (M631 of APP) for oxidative damage, indices of spatial learning and memory were not significantly improved by the M631L substitution. Furthermore, a genetically matched line with a different mutation-PDAPP(D664A)-showed the reverse: no reduction in oxidative damage but marked improvement in memory. This is the first in vivo study to demonstrate the requirement for Abeta residue Met35 for oxidative stress in the brain of a mammalian model of Alzheimer disease. However, in this specific transgenic mouse model of AD, oxidative stress is neither required nor sufficient for memory abnormalities.
19854267	8	17	oxidative	Disease	MESH:D028361
19854267	37	54	Alzheimer disease	Disease	MESH:D000544
19854267	55	70	transgenic mice	Species	10090
19854267	169	178	oxidative	Disease	MESH:D028361
19854267	233	250	Alzheimer disease	Disease	MESH:D000544
19854267	280	298	dementing disorder	Disease	MESH:D009358
19854267	328	343	transgenic mice	Species	10090
19854267	353	370	Alzheimer disease	Disease	MESH:D000544
19854267	377	381	mice	Species	10090
19854267	424	429	human	Species	9606
19854267	430	455	amyloid precursor protein	Gene	351
19854267	470	479	oxidative	Disease	MESH:D028361
19854267	578	593	3-nitrotyrosine	Chemical	MESH:C002744
19854267	599	604	lipid	Chemical	MESH:D008055
19854267	644	663	4-hydroxy-2-nonenal	Chemical	MESH:C027576
19854267	671	680	oxidative	Disease	MESH:D028361
19854267	722	755	methionine residue at position 35	ProteinMutation	tmVar:p|Allele|M|35;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
19854267	785	790	Abeta	Gene	11820
19854267	816	825	oxidative	Disease	MESH:D028361
19854267	899	904	PDAPP	Disease	
19854267	905	909	mice	Species	10090
19854267	918	923	M631L	ProteinMutation	tmVar:p|SUB|M|631|L;HGVS:p.M631L;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
19854267	1099	1108	oxidative	Disease	MESH:D028361
19854267	1146	1151	M631L	ProteinMutation	tmVar:p|SUB|M|631|L;HGVS:p.M631L;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
19854267	1153	1157	mice	Species	10090
19854267	1198	1218	Met35 residue to Leu	ProteinMutation	tmVar:p|SUB|M|35|L;HGVS:p.M35L;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
19854267	1226	1231	Abeta	Gene	11820
19854267	1272	1277	Abeta	Gene	11820
19854267	1321	1326	M631L	ProteinMutation	tmVar:p|SUB|M|631|L;HGVS:p.M631L;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
19854267	1327	1331	mice	Species	10090
19854267	1470	1487	Met at residue 35	ProteinMutation	tmVar:p|Allele|M|35;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;CorrespondingSpecies:10090
19854267	1495	1500	Abeta	Gene	11820
19854267	1511	1515	M631	ProteinMutation	tmVar:p|Allele|M|631;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
19854267	1528	1537	oxidative	Disease	MESH:D028361
19854267	1624	1629	M631L	ProteinMutation	tmVar:p|SUB|M|631|L;HGVS:p.M631L;VariantGroup:1;CorrespondingGene:351;CorrespondingSpecies:9606
19854267	1716	1721	D664A	ProteinMutation	tmVar:p|SUB|D|664|A;HGVS:p.D664A;VariantGroup:2;CorrespondingGene:351;CorrespondingSpecies:9606
19854267	1759	1768	oxidative	Disease	MESH:D028361
19854267	1877	1882	Abeta	Gene	11820
19854267	1901	1910	oxidative	Disease	MESH:D028361
19854267	1936	1945	mammalian	Species	9606
19854267	1955	1972	Alzheimer disease	Disease	MESH:D000544
19854267	2011	2016	mouse	Species	10090
19854267	2026	2028	AD	Disease	MESH:D000544
19854267	2030	2039	oxidative	Disease	MESH:D028361
19854267	2086	2106	memory abnormalities	Disease	MESH:D008569
19854267	Negative_Correlation	MESH:D028361	HGVS:p.M631L;CorrespondingGene:351
19854267	Negative_Correlation	MESH:D028361	CorrespondingGene:351;CorrespondingSpecies:10090;OriginalGene:11820;VariantGroup:0;tmVar:p
19854267	Association	MESH:D008055	MESH:D028361
19854267	Negative_Correlation	MESH:D028361	HGVS:p.M35L;CorrespondingGene:351
19854267	Association	MESH:D028361	11820
19854267	Positive_Correlation	MESH:C002744	MESH:D028361
19854267	Positive_Correlation	MESH:C002744	MESH:D000544
19854267	Positive_Correlation	MESH:C027576	MESH:D028361
19854267	Association	MESH:D028361	351

